Results 81 to 90 of about 29,185 (239)

Disseminated HIV-Associated Kaposi’s Sarcoma With High CD4 Cell Count And Low Viral Load

Galicia Clínica, 2017
Kaposi’s sarcoma is considered an acquired immunodeficiency syndrome-defining illness and is caused by human herpesvirus 8. It has been associated with patients infected with human immunodeficiency virus (HIV) who have CD4 T lymphocytes
Diana Pereira Anjos, Ana João Sá, André Paupério, Mari Mesquita   +3 more
doaj   +1 more source

Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China [PDF]

, 2017
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the infectious etiologic agent associated with Kaposi’s sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease.
Cui, Meng, Han, Li-Li, Liu, Zhen-Qiu, Shu, Zhan-Jun, Wood, Charles, Yang, Yang, Zeng, Yan, Zhang, Tiejun, Zheng, Jun   +8 more
core   +1 more source

Antiretroviral therapy and Kaposi’s sarcoma trends and outcomes among adults with HIV in Latin America [PDF]

, 2021
Jessica L. Castilho, Ahra Kim, Cathy A. Jenkins, Beatriz Grinsztejn, Eduardo Gotuzzo, Valeria Fink, Denis Padgett, Pablo F. Belaunzarán-Zamudio, Brenda Crabtree‐Ramírez, Maria Mercedes Loureiro Escuder, Rosa de Alencar Souza, Simone de Barros Tenore, Sidnei Rana Pimentel, Maria Letícia Rodrigues Ikeda, Paulo Ricardo de Alencastro, Unai Tupinanbás, Carlos Brites, Estela Luz, Juliana dos Santos Barbosa Netto, Claudia P. Cortés, Alexandre Grangeiro, Bryan E. Shepherd, Catherine C. McGowan, the Caribbean, Central, South America network for HIV Epidemiology (CCASAnet)   +23 more
openalex   +1 more source

Patient‐ and caregiver‐reported barriers to chemotherapy in nine sub‐Saharan African countries: A cross‐sectional survey among population‐based registries

International Journal of Cancer, Volume 158, Issue 10, Page 2684-2696, 15 May 2026.
What's New? Increasing cancer incidence and mortality in low‐ and middle‐income countries has heightened concerns about limited resources and barriers to care. This challenge is particularly urgent in Sub‐Saharan Africa (SSA), where cancer rates are rising sharply. Here, data from population‐based cancer registries in nine SSA countries was assessed to
Tamara König, Nikolaus Christian Simon Mezger, Ole Stoeter, Phoebe Mary Amulen, Margaret Borok, Gladys C. Chesumbai, Moudiongui MBoungou Dimitry, Ima‐Obong Ekanem, Adugna Fekadu, Bakarou Kamaté, William Muller, Alex Alain Kabena Nzambikolo, Abidemi Omonisi, Furaha Serventi, Markus Wallwiener, Biying Liu, Donald Maxwell Parkin, Pablo Sandro Carvalho Santos, Eva Johanna Kantelhardt, Eric Sven Kroeber   +19 more
wiley   +1 more source

Bleomycin electrosclerotherapy for kaposiform hemangioendothelioma with Kasabach–Merritt phenomenon in an adult

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Jakob Veeser, Raphael Wilhelm, Janina Dietzel, Yalda Ghoreishi, Nora Laubach, Nora Elspaß, Maike Kaufhold, Beate Weidenthaler‐Barth, Christian Rose, Stephan Grabbe, Henner Stege, Hadrian Nassabi   +11 more
wiley   +1 more source

Development and psychometric properties of a general cancer stigma scale

International Journal of Cancer, Volume 158, Issue 10, Page 2747-2759, 15 May 2026.
What's New? Cancer‐related stigma can fuel anxiety and depression and lead to self‐isolation, delayed treatment, and decreased quality of life. The extent to which stigma impacts cancer patients, however, remains uncertain. This study applied mixed methods in high‐ and low‐income settings, with cohorts in the U.S. state of Utah and Lilongwe, Malawi, to
Stephen M. Kimani, Gita Suneja, Agatha Bula, Chaorong Wu, Abhilasha Khatri, Nehal Bakshi, Olivia R. Hanson, Aparna Mangadu, Mercy Tsidya, Melissa A. Stockton, Brandon A. Knettel, Melissa H. Watt   +11 more
wiley   +1 more source

Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome [PDF]

, 2015
Latency-associated nuclear antigen 1 (LANA1) of Kaposi's sarcoma-associated herpesvirus (KSHV) is implicated in the maintenance of the viral genome during latent infection.
Choe, Joonho, Gwack, Yousang, Lee, Daeyoup, Lim, Chunghun, Sohn, Hekwang   +4 more
core   +1 more source

Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV

International Journal of Cancer, Volume 158, Issue 9, Page 2298-2308, 1 May 2026.
What's new? This large nation‐wide cohort study provides a comprehensive 20‐year analysis of cancer trends among people living with HIV in France, highlighting persistent excess risks for virus‐related cancers despite effective antiretroviral therapy and immune restoration.
Sophie Grabar, Paula Lakrout, Valérie Potard, Aurélien Belot, Jacques Cadranel, Christine Jacomet, Christine Katlama, Esaïe Marshall, Olivier Lambotte, Romain Palich, Sylvie Ronot‐Bregigeon, Jean‐Philippe Spano, Anne‐Marie Bouvier, Alain Makinson, Dominique Costagliola   +14 more
wiley   +1 more source

Primary Kaposi's Sarcoma of Penis

Journal of Research in Medical Sciences, 2005
Kaposi's sarcoma rarely involves penis and is usually accompanied by other cutaneous, mucous or visceral lesions. We report a case of Kaposi's sarcoma of penis. Although Kaposi's sarcoma is known to be associated with an altered immune status ...
P Mahzooni, D Taheri, A Gookizadeh
doaj  

Lymphangioma-Like Kaposi’s Sarcoma Presenting as Gangrene

Case Reports in Oncological Medicine, 2013
Kaposi’s sarcoma (KS) is a multicentric vascular neoplasm associated with the Kaposi’s sarcoma-associated herpes virus (KSHV). KS can occur in immunocompromised patients as well as certain populations in Africa or in the Mediterranean. Less than 5% of KS
Eitan R. Friedman, Lesley Farquharson, Jessica Warsch, Ran Huo, Clara Milikowski, Margarita Llinas   +5 more
doaj   +1 more source